{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:02:45Z","timestamp":1787151765029,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T00:00:00Z","timestamp":1654905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100008349","name":"Universit\u00e4t Duisburg-Essen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008349","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Routine skin cancer screening (SCS) is covered by the German statutory health insurance (SHI) since 2008. The objective of this study was to compare direct healthcare costs between patients in whom skin cancer was detected by routine SCS and patients in whom skin cancer was not detected by routine SCS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective observational study of administrative claims data from a large German SHI was performed. Patients with a diagnosis of malignant melanoma (MM) or non-melanoma skin cancer (NMSC) diagnosed in 2014 or 2015 were included. Costs were obtained for one year before and one year after diagnosis and analyzed in a difference-in-differences approach using regression models. Frequency matching was applied and risk adjustment was performed. Additional analyses were conducted, separately for specific age groups, excluding persons who died during the observation period and without taking costs for screening into consideration.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 131,801 patients were included, of whom 13,633 (10.3%) had a diagnosis of MM and 118,168 (89.7%) had a diagnosis of NMSC. The description of total costs (without risk adjustment) shows lower mean total costs among patients whose skin cancer was detected via routine SCS compared to patients in whom skin cancer was not detected by routine SCS (MM: \u20ac5,326 (95% confidence interval (CI) \u20ac5,073; \u20ac5,579) vs. \u20ac9,038 (95% CI \u20ac8,629; \u20ac9,448); NMSC: \u20ac4,660 (95% CI \u20ac4,573; \u20ac4,745) vs. \u20ac5,890 (95% CI \u20ac5,813; \u20ac5,967)). Results of the regression analysis show cost savings of 18.8% (95% CI -23.1; -8.4) through routine SCS for patients with a diagnosis of MM. These cost savings in MM patients were more pronounced in patients younger than 65\u00a0years of age. For patients with a diagnosis of NMSC, the analysis yields a non-substantial increase in costs (2.5% (95% CI -0.1; 5.2)).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Cost savings were detected for persons with an MM diagnosed by routine SCS. However, the study could not detect lower costs due to routine SCS in the large fraction of persons with a diagnosis of NMSC. These results offer important insights into the cost structure of the routine SCS and provide opportunities for refinements.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-022-08141-9","type":"journal-article","created":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T18:02:40Z","timestamp":1654970560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["One-year follow-up healthcare costs of patients diagnosed with skin cancer in Germany: a claims data analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Christian","family":"Speckemeier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Pahmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Trocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrin","family":"Schuldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegard","family":"Lax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Nonnemacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Dr\u00f6ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Stang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Wasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Neusser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,11]]},"reference":[{"issue":"1","key":"8141_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.6001\/actamedica.v24i1.3460","volume":"24","author":"A Lideikait\u0117","year":"2017","unstructured":"Lideikait\u0117 A, Moz\u016braitien\u0117 J, Letautien\u0117 S. Analysis of prognostic factors for melanoma patients. Acta Med Litu. 2017;24(1):25\u201334. https:\/\/doi.org\/10.6001\/actamedica.v24i1.3460.","journal-title":"Acta Med Litu"},{"key":"8141_CR2","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.2741\/1877","volume":"11","author":"M Berwick","year":"2006","unstructured":"Berwick M, Wiggins C. The current epidemiology of cutaneous malignant melanoma. Front BioSci. 2006;11:1244\u201354. https:\/\/doi.org\/10.2741\/1877.","journal-title":"Front BioSci"},{"issue":"11","key":"8141_CR3","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/COC.0000000000000604","volume":"42","author":"AM Blakely","year":"2019","unstructured":"Blakely AM, Cohen JT, Comissiong DS, Vezeridis MP, Miner TJ. Prognosis and management of thick and ultrathick melanoma. Am J Clin Oncol. 2019;42(11):824\u20139. https:\/\/doi.org\/10.1097\/COC.0000000000000604.","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"8141_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0360-3016(99)00547-7","volume":"47","author":"B Guix","year":"2000","unstructured":"Guix B, Finestres F, Tello J, Palma C, Martinez A, Guix J, et al. Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds. Int J Radiat Oncol Biol Phys. 2000;47(1):95\u2013102. https:\/\/doi.org\/10.1016\/s0360-3016(99)00547-7.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8141_CR5","doi-asserted-by":"publisher","unstructured":"Leiter U, Eigentler T, Garbe C. Epidemiology of Skin Cancer. In: Reichrath J, editor. Sunlight, Vitamin D and Skin Cancer. 2014. https:\/\/doi.org\/10.1007\/978-1-4939-0437-2_7. Accessed 7 Jul 2021.","DOI":"10.1007\/978-1-4939-0437-2_7"},{"key":"8141_CR6","doi-asserted-by":"publisher","unstructured":"Robert Koch Institute. Krebs in Deutschland f\u00fcr 2017\/2018. 2021. https:\/\/doi.org\/10.25646\/8353. Accessed 5 Jan 2022.","DOI":"10.25646\/8353"},{"key":"8141_CR7","unstructured":"Robert Koch Institute. Bericht zum Krebsgeschehen in Deutschland 2016. 2016. https:\/\/edoc.rki.de\/handle\/176904\/3264. Accessed 7 Jul 2021."},{"issue":"11","key":"8141_CR8","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1111\/jdv.14990","volume":"32","author":"J Augustin","year":"2018","unstructured":"Augustin J, Kis A, Sorbe C, Sch\u00e4fer I, Augustin M. Epidemiology of skin cancer in the German population: impact of socioeconomic and geographic factors. J Eur Acad Dermatol Venereol. 2018;32(11):1906\u201313. https:\/\/doi.org\/10.1111\/jdv.14990.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 8","key":"8141_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/jdv.15967","volume":"33 Suppl 8","author":"A Stang","year":"2019","unstructured":"Stang A, Khil L, Kaj\u00fcter H, Pandeya N, Schmults CD, Ruiz ES, et al. Incidence and mortality for cutaneous squamous cell carcinoma: comparison across three continents. J Eur Acad Dermatol Venereol. 2019;33 Suppl 8(Suppl 8):6\u201310. https:\/\/doi.org\/10.1111\/jdv.15967.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"8141_CR10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jaad.2010.11.016","volume":"66","author":"EW Breitbart","year":"2012","unstructured":"Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert R, Volkmer B, et al. Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol. 2012;66(2):201\u201311. https:\/\/doi.org\/10.1016\/j.jaad.2010.11.016.","journal-title":"J Am Acad Dermatol"},{"issue":"38","key":"8141_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.3238\/arztebl.2015.0629","volume":"112","author":"A Katalinic","year":"2015","unstructured":"Katalinic A, Eisemann N, Waldmann A. Skin Cancer screening in Germany. Documenting melanoma incidence and mortality from 2008 to 2013. Dtsch Arztebl Int. 2015;112(38):629\u201334. https:\/\/doi.org\/10.3238\/arztebl.2015.0629.","journal-title":"Dtsch Arztebl Int"},{"key":"8141_CR12","unstructured":"Gemeinsamer Bundesausschuss. Richtlinie des Gemeinsamen Bundesausschusses \u00fcber die Fr\u00fcherkennung von Krebserkrankungen. 2020. https:\/\/www.g-ba.de\/downloads\/62-492-2238\/KFE-RL_2020-06-18_iK-2020-08-28.pdf. Accessed Jul 10 2021."},{"issue":"1","key":"8141_CR13","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00103-013-1876-1","volume":"57","author":"N Eisemann","year":"2014","unstructured":"Eisemann N, Waldmann A, Katalinic A. Inzidenz des malignen Melanoms und Ver\u00e4nderung der stadienspezifischen Inzidenz nach Einf\u00fchrung eines Hautkrebsscreenings in Schleswig-Holstein. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014;57(1):77\u201383. https:\/\/doi.org\/10.1007\/s00103-013-1876-1.","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"issue":"3","key":"8141_CR14","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1177\/0969141317734003","volume":"25","author":"N Eisemann","year":"2018","unstructured":"Eisemann N, Waldmann A, Holleczek B, Katalinic A. Observed and expected mortality in the German skin cancer screening pilot project SCREEN. J Med Screen. 2018;25(3):166\u20138. https:\/\/doi.org\/10.1177\/0969141317734003.","journal-title":"J Med Screen"},{"issue":"3","key":"8141_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10198-017-0888-4","volume":"19","author":"M Kaiser","year":"2018","unstructured":"Kaiser M, Schiller J, Schreckenberger C. The effectiveness of a population-based skin cancer screening program: evidence from Germany. Eur J Health Econ. 2018;19(3):355\u201367. https:\/\/doi.org\/10.1007\/s10198-017-0888-4.","journal-title":"Eur J Health Econ"},{"issue":"1","key":"8141_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/bjd.20658","volume":"186","author":"T Datzmann","year":"2021","unstructured":"Datzmann T, Schoffer O, Meier F, Seidler A, Schmitt J. Are patients benefiting from participation in the German skin cancer screening programme? A large cohort study based on administrative data. Br J Dermatol. 2021;186(1):69\u201377. https:\/\/doi.org\/10.1111\/bjd.20658.","journal-title":"Br J Dermatol"},{"issue":"3","key":"8141_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10654-017-0348-6","volume":"33","author":"A Stang","year":"2018","unstructured":"Stang A, Joeckel KH, Heidinger O. Skin cancer rates in North Rhine-Westphalia, Germany before and after the introduction of the nationwide skin cancer screening program (2000\u20132015). Eur J Epidemiol. 2018;33(3):303\u201312. https:\/\/doi.org\/10.1007\/s10654-017-0348-6.","journal-title":"Eur J Epidemiol"},{"key":"8141_CR18","unstructured":"Veit C, Lueken F, Meisheimer O. Evaluation der Screeninguntersuchungen auf Hautkrebs gem\u00e4\u00df Krebsfr\u00fcherkennungs-Richtlinie des Gemeinsamen Bundesausschusses. Abschlussbericht 2009 \u2013 2010. 2015. https:\/\/www.bqs.de\/evaluationen-und-studien\/hautkrebsscreening-evaluation-der-screeninguntersuchungen.php. Accessed Jul 20 2021."},{"issue":"5","key":"8141_CR19","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/ced.14550","volume":"46","author":"M Krensel","year":"2021","unstructured":"Krensel M, Andrees V, Mohr N, Hischke S. Costs of routine skin cancer screening in Germany: a claims data analysis. Clin Exp Dermatol. 2021;46(5):842\u201350. https:\/\/doi.org\/10.1111\/ced.14550.","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"8141_CR20","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/s0167-6296(01)00086-8","volume":"20","author":"WG Manning","year":"2001","unstructured":"Manning WG, Mullahy J. Estimating log models: to transform or not to transform? J Health Econ. 2001;20(4):461\u201394. https:\/\/doi.org\/10.1016\/s0167-6296(01)00086-8.","journal-title":"J Health Econ"},{"issue":"1","key":"8141_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8\u201327. https:\/\/doi.org\/10.1097\/00005650-199801000-00004.","journal-title":"Med Care"},{"issue":"11","key":"8141_CR22","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130\u20139. https:\/\/doi.org\/10.1097\/01.mlr.0000182534.19832.83.","journal-title":"Med Care"},{"issue":"11","key":"8141_CR23","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/MLR.0b013e31822ebe11","volume":"49","author":"RN Kuo","year":"2011","unstructured":"Kuo RN, Dong YH, Liu JP, Chang CH, Shau WY, Lai MS. Predicting healthcare utilization using a pharmacy-based metric with the WHO\u2019s Anatomic Therapeutic Chemical algorithm. Med Care. 2011;49(11):1031\u20139. https:\/\/doi.org\/10.1097\/MLR.0b013e31822ebe11.","journal-title":"Med Care"},{"key":"8141_CR24","unstructured":"Woolridge JM. Introductory Econometrics. A Modern Approach. 2012. https:\/\/economics.ut.ac.ir\/documents\/3030266\/14100645\/Jeffrey_M._Wooldridge_Introductory_Econometrics_A_Modern_Approach__2012.pdf. Accessed Jul 5 2021."},{"issue":"1","key":"8141_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1468-3083.2011.04014.x","volume":"26","author":"S Guther","year":"2012","unstructured":"Guther S, Ramrath K, Dyall-Smith D, Landthaler M, Stolz W. Development of a targeted risk-group model for skin cancer screening based on more than 100,000 total skin examinations. J Eur Acad Dermatol Venereol. 2012;26(1):86\u201394. https:\/\/doi.org\/10.1111\/j.1468-3083.2011.04014.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"8141_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jaad.2016.07.045","volume":"76","author":"A Brunssen","year":"2017","unstructured":"Brunssen A, Waldmann A, Eisemann N, Katalinic A. Impact of skin cancer screening and secondary prevention campaigns on skin cancer incidence and mortality: A systematic review. J Am Acad Dermatol. 2017;76(1):129-39.e10. https:\/\/doi.org\/10.1016\/j.jaad.2016.07.045.","journal-title":"J Am Acad Dermatol"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-022-08141-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-022-08141-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-022-08141-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T18:02:48Z","timestamp":1654970568000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-022-08141-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,11]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["8141"],"URL":"https:\/\/doi.org\/10.1186\/s12913-022-08141-9","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,11]]},"assertion":[{"value":"10 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethics committee of the University Hospital Essen. All methods were carried out in accordance with relevant guidelines and regulations. All data was used solely for the purpose of the study and the authors had no access to identifying information. As the nature of the study is retrospective ethics committee of the University Hospital Essen and the AOK Research Institute have waived consent for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author declares no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"771"}}